Clinical & translational oncology

• 

  Año 2019, Vol. 21, Número 11

  • Combined strategies for tumor immunotherapy with nanoparticles

    K. Savitsky, X. Yu

    • Resumen

    págs. 1441-1449

    

  • Central nervous system ependymoma: clinical implications of the new molecular classification, treatment guidelines and controversial issues

    P. D. Delgado López, E. Mª. Corrales García, E. Alonso García, R. García-Leal, Rosario González Rodrigálvarez, Elena Araus Galdós, Javier Martín Alonso

    • Resumen

    págs. 1450-1463

    

  • Consensus on the use of immune-related response criteria to evaluate the efficacy of immunotherapy in non-small cell lung cancer

    Mariano Provencio Pulla, Enric Carcereny Costa, Ángel Artal Cortés

    • Resumen

    págs. 1464-1471

    

  • Applying Data Science methods and tools to unveil healthcare use of lung cancer patients in a teaching hospital in Spain

    Juan Luis Cruz Bermúdez, C. Parejo, Francisco Martínez Ruíz, J. C. Sánchez González, A.J. Ramos Martín Vegue, Ana Royuela Vicente, Alejandro Rodríguez González, Ernestina Menasalvas, Mariano Provencio Pulla

    • Resumen

    págs. 1472-1481

    

  • Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma

    J.W. Feng, X.H. Yang, B.Q. Wu, D.L. Sun, Y. Jiang, Z. Qu

    • Resumen

    págs. 1482-1491

    

  • Skin and lung toxicity in synchronous bilateral breast cancer treated with volumetric-modulated arc radiotherapy: a mono-institutional experience

    M. Valli, S. Cima, D. Gaudino, R. Cartolari, Letizia Deantonio, M. Frapolli, D. Daniele, G.A. Pesce, F. Martucci, N.C. Azinwi, D. Bosetti, S. Presilla, A. Richetti

    • Resumen

    págs. 1492-1498

    

  • Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis

    Y. Wang, J. Zhang, S. Guo, Z. Dong, X. Meng, G. Zheng, D. Yang, Z. Zheng, Y. Zhao

    • Resumen

    págs. 1499-1509

    

  • Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer

    O. Köstek, N.C. Demircan, A. Gökyer, A. Küçükarda, B.S. Sunal, M.B. Hacıoğlu, H. Eslame, Sezgi Sarıkaya Solak, E. Yılmaz, S. Uzunoğlu, N. Tunçbilek, İ. Çiçin, B. Erdoğan

    • Resumen

    págs. 1510-1517

    

  • Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib

    A. Gökyer, A. Küçükarda, O. Köstek, M.B. Hacıoğlu, B.S. Sunal, N.C. Demircan, S. Uzunoğlu, Sezgi Sarıkaya Solak, K. İşsever, İ. Çiçin, B. Erdoğan

    • Resumen

    págs. 1518-1523

    

  • Clinical characteristics and prognosis of different primary tumor location in colorectal cancer: a population-based cohort study

    C. Zheng, F. Jiang, H. Lin, S. Li

    • Resumen

    págs. 1524-1531

    

  • Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy?

    A. Bruni, G. Ingrosso, F. Trippa, M. Di Staso, B. Lanfranchi, L. Rubino, S. Parente, L. Frassinelli, Ernesto Maranzano, R. Santoni, Maria Chiara Sighinolfi, F. Lohr, E. Mazzeo

    • Resumen

    págs. 1532-1537

    

  • Association of neurologic manifestations and CEA levels with the diagnosis of brain metastases in lung cancer patients

    Bernardo Cacho Díaz, H. Spínola Maroño, L.G. Mendoza Olivas, A. Monroy Sosa, Gervith Reyes Soto, Óscar Arrieta

    • Resumen

    págs. 1538-1542

    

  • Comparison of efficacy of HCAG and FLAG re-induction chemotherapy in acute myeloid leukemia patients of low- and intermediate-risk groups

    J.Y. Zhang, K. Yu, L.J. Li

    • Resumen

    págs. 1543-1550

    

  • Neural stem cells promote glioblastoma formation in nude mice

    J. Wang, J. Liu, H. Meng, Y. Guan, Y. Yin, Z. Zhao, G. Sun, A. Wu, L. Chen, X. Yu

    • Resumen

    págs. 1551-1560

    

  • Role of multi-modality functional imaging in differentiation between benign and malignant thyroid 18F-fluorodeoxyglucose incidentaloma

    H. Shi, Z. Yuan, C. Yang, J. Zhang, C. Liu, J. Sun, X. Ye

    • Resumen

    págs. 1561-1567

    

  • Effectiveness of fentanyl pectin nasal citrate in controlling episodes of breakthrough cancer pain triggered by routine radiotherapy procedures

    José Pardo Masferrer, A. Mena, Esther Jimenez Jimenez, Neus Aymar, Irene Ortiz González, Raquel Roncero, F. Mestre, Monserrat Vidal Fernández

    • Resumen

    págs. 1568-1572

    

  • Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years’ experience of a reference centre in Spain

    Beatriz Castelo Fernández, David Viñal, Rocío Maseda Pedrero, L. Ostios García, D. Sánchez, B. García Salvatierra, M.J. Escámez, L. Martínez Santamaría, M. Del Río, Marta Mora Rillo, Y. Vilches Aguirre, M. Beato Merino, Juan Carlos López Gutiérrez, Nuria Romero Laorden, C. Santos, J. Miranda, R. Lucas

    • Resumen

    págs. 1573-1577

    

  • Interplay between neural stem cells and glioblastoma: possible role of neurotrophin signaling

    Rafael Roesler

    págs. 1578-1579

    

  • Correction to: BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines

    Marta Cuadros Celorrio, V. Sánchez Martín, Antonio Herrera-Merchan, C. Baliñas, J. Martín Padrón, Laura Boyero Corral, P. Peinado, P. P. Medina

    págs. 1580-1580

    

  • Expression of Concern: BRG1 regulation by miR-155 in human leukemia and lymphoma cell lines

    Marta Cuadros Celorrio, V. Sánchez Martín, Antonio Herrera-Merchan, C. Baliñas, J. Martín Padrón, Laura Boyero Corral, P. Peinado, P. P. Medina

    págs. 1581-1581